Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yaguo Zheng

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
BMC Women'S Health|April 5, 2024
Reproductive factors and risk of cardiovascular diseases and all-cause and cardiovascular mortality in American women: NHANES 2003-2018Yufeng Yan, Hongjing Lu, Song Lin, et al.
Journal of the Endocrine Society|July 8, 2024
Association Between Systemic Immune Inflammation Index and Diabetes Mellitus in the NHANES 2003-2018 PopulationYufeng Yan, Hongjing Lu, Yaguo Zheng, et al.
Cardiovascular Drugs and Therapy|October 26, 2024
Ticagrelor versus Clopidogrel in Patients with left main Coronary Artery StentingYufeng Yan, Haimei Xu, Yingying Zhao, et al.
Echocardiography (Mount Kisco, N.Y.)|December 31, 2024
The Evaluation of Right Ventricular Synchrony by Two-Dimensional Speckle Tracking Echocardiography in Connective Tissue Disease-Associated Pulmonary Arterial HypertensionHong Ma, HongPing Wu, XiaoXuan Sun, et al.
Platelets|September 11, 2019
Percutaneous coronary intervention in patients with essential thrombocythemia: case reports and literature reviewYaguo Zheng, Tian Xu, Liang Chen, et al.
Coronary Artery Disease|January 22, 2025
Comparison of ticagrelor and clopidogrel in primary percutaneous coronary intervention patients: a single-center retrospective studyYufeng Yan, Haimei Xu, Yingying Zhao, et al.
European Journal of Clinical Pharmacology|September 13, 2013
Prostanoid therapy for pulmonary arterial hypertension: a meta-analysis of survival outcomesYaguo Zheng, Tao Yang, Guo Chen, et al.
Frontiers in Cardiovascular Medicine|May 11, 2026
Triglyceride levels and all-cause mortality in patients with left main coronary artery disease undergoing percutaneous coronary interventionHongJing Lu, Yufeng Yan, Haimei Xu, et al.
Pharmacology, Biochemistry, and Behavior|April 17, 2012
Intrathecal administration of roscovitine attenuates cancer pain and inhibits the expression of NMDA receptor 2B subunit mRNARui Zhang, Yue Liu, Juan Zhang, et al.
Journal of Cardiovascular Pharmacology|November 5, 2015
Inhibition of FGFR Signaling With PD173074 Ameliorates Monocrotaline-induced Pulmonary Arterial Hypertension and Rescues BMPR-II ExpressionYaguo Zheng, Hong Ma, Enci Hu, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
BMC Women'S Health|April 5, 2024
Reproductive factors and risk of cardiovascular diseases and all-cause and cardiovascular mortality in American women: NHANES 2003-2018Yufeng Yan, Hongjing Lu, Song Lin, et al.
Journal of the Endocrine Society|July 8, 2024
Association Between Systemic Immune Inflammation Index and Diabetes Mellitus in the NHANES 2003-2018 PopulationYufeng Yan, Hongjing Lu, Yaguo Zheng, et al.
Cardiovascular Drugs and Therapy|October 26, 2024
Ticagrelor versus Clopidogrel in Patients with left main Coronary Artery StentingYufeng Yan, Haimei Xu, Yingying Zhao, et al.
Echocardiography (Mount Kisco, N.Y.)|December 31, 2024
The Evaluation of Right Ventricular Synchrony by Two-Dimensional Speckle Tracking Echocardiography in Connective Tissue Disease-Associated Pulmonary Arterial HypertensionHong Ma, HongPing Wu, XiaoXuan Sun, et al.
Platelets|September 11, 2019
Percutaneous coronary intervention in patients with essential thrombocythemia: case reports and literature reviewYaguo Zheng, Tian Xu, Liang Chen, et al.
Coronary Artery Disease|January 22, 2025
Comparison of ticagrelor and clopidogrel in primary percutaneous coronary intervention patients: a single-center retrospective studyYufeng Yan, Haimei Xu, Yingying Zhao, et al.
European Journal of Clinical Pharmacology|September 13, 2013
Prostanoid therapy for pulmonary arterial hypertension: a meta-analysis of survival outcomesYaguo Zheng, Tao Yang, Guo Chen, et al.
Frontiers in Cardiovascular Medicine|May 11, 2026
Triglyceride levels and all-cause mortality in patients with left main coronary artery disease undergoing percutaneous coronary interventionHongJing Lu, Yufeng Yan, Haimei Xu, et al.
Pharmacology, Biochemistry, and Behavior|April 17, 2012
Intrathecal administration of roscovitine attenuates cancer pain and inhibits the expression of NMDA receptor 2B subunit mRNARui Zhang, Yue Liu, Juan Zhang, et al.
Journal of Cardiovascular Pharmacology|November 5, 2015
Inhibition of FGFR Signaling With PD173074 Ameliorates Monocrotaline-induced Pulmonary Arterial Hypertension and Rescues BMPR-II ExpressionYaguo Zheng, Hong Ma, Enci Hu, et al.
Pageof 3